期刊文献+

乳腺癌^(99)Tc^m-HL91乏氧显像与^(18)F-FDG符合显像的对比研究 被引量:3

Comparative study of ^(99)Tc^m-HL91 hypoxia imaging and ^(18)F-FDG DHC imaging in breast cancer
下载PDF
导出
摘要 目的对比研究99Tcm-HL91显像和18F-FDG显像诊断乳腺癌的临床价值。方法31例乳腺癌患者行99Tcm-HL91和18F-FDG显像,利用计算机感兴趣区(ROI)技术计算T/NT值(病灶计数/对侧计数),定性和半定量法计算诊断灵敏度。结果病灶摄取18F-FDG和99Tcm-HL91的T/NT值为(3.16±0.57)、(2.14±0.36)(P<0.01);浸润性导管癌和浸润性小叶癌摄取18F-FDG T/NT值为(3.14±0.43)、(3.19±0.27)(P>0.05),摄取99Tcm-HL91 T/NT值为(2.16±0.38)、(2.10±0.32)(P>0.05);病灶T/NT值分布18F-FDG为1.56~9.43(中位值3.15),99Tcm-HL91为1.36~6.28(中位值2.95),两者呈正相关(P<0.01);定性法18F-FDG诊断灵敏度为90%,而99Tcm-HL91为84%;半定量以T/NT值2.0为标准,18F-FDG灵敏度为97%,以T/NT值1.5为标准,99Tcm-HL91灵敏度为90%。结论乳腺癌组织对18F-FDG和99Tcm-HL91均有明显的摄取,呈显著正相关;99Tcm-HL91诊断乳腺癌有较高灵敏度,具有一定临床价值。 Objective To study and compare the diagnostic value of ^99Tc^m-4, 9-diaza-3, 3, 10, 10-tetramethyldodecan-2, 11-dione dioxime (HL91) hypoxia imaging and ^18F-fluorodeoxyglucose (FDG) dual-head coincidence (DHC) imaging in primary breast cancer. Methods Thirty-one patients with primary breast cancer diagnosed by fine needle aspiration were underwent ^99Tc^m-HL91 and ^18 F-FDG tomography fusion imaging. Regions of interest (ROD were drawn on the tumor (T) and contralateral normal breast tissue (NT), T/NT ratios were measured for all scans. The diagnostic sensitivity was measured by qualitative and semi-quantitative analysis. Results The T/NT ratio of ^18F-FDG and ^99Tc^m-HL91 in breast cancer were (3.16±0. 57), (2.14±0.36) (P〈0. 01) ; T/NT ratios of ^18F-FDG in IDC (infiltrating ductal carcinoma) and ILC (infiltrating lobular carcinoma) were (3.14±0.43) and (3. 19±0.27) (P〉0. 05), and of ^99Tc^m-HL91 were (2. 16±0. 38) and (2. 10±0. 32) (P〉0. 05). In all 31 patients T/NT ratios of ^18F-FDG ranged from 1.56 to 9.43 (median: 3. 15) and of ^99Tc^m-HL91 was 1.36-6.28 (median: 2.95). A linear correlation was found between them. The sensitivity of ^18F-FDG and ^99Tc^m-HL91 were 90% (28/31), 84% (26/31) by qualitative analysis. Using 2.0 of T/TN as diagnostic threshold to ^18F- FDG the sensitivity was 97 %, and 1.5 to ^99Tc^m-HL91 the sensitivity was 90 % in the semi-quantitative diagnosis. Conclusion The breast cancer can uptake ^18F-FDG and ^99Tc^m-HL91 obviously, and a strong positive correlation was found between the uptake of them; ^99Tc^m-HL91 imaging possesses higher sensitivity and a certain clinical value in diagnosing breast cancer.
出处 《中国医学影像技术》 CSCD 北大核心 2006年第5期767-769,共3页 Chinese Journal of Medical Imaging Technology
关键词 乳腺肿瘤 放射性核素显像 ^99TC^M-HL91 氟脱氧葡萄糖F18 Breast neoplasms Radionuclide imaging ^99Tc^m-HL91 Fluorodeoxyglucose F18
  • 相关文献

参考文献9

  • 1Tatsumi M,Yutoni K,Kusuoka H,et al.Technetium-99m-HL91uptake as a tumor hypoxia marker:relationship to tumor blood flow[J].Eur J Nucl Med,1999,26(2):91-94.
  • 2姚稚明,屈婉莹,周颖,朱明,朱霖.^(99m)Tc-HL91肿瘤乏氧显像及肿瘤坏死对显像影响的实验研究[J].中国医学影像技术,1999,15(9):736-738. 被引量:5
  • 3Kinuya S,Yokoyama K,Li XF,et al.Hypoxia-induced alteration of tracer accumulation in cultured cancer cells and xenografts in mice:implications for pre-therapeutic prediction of treatment outcomes with 99Tcm-sestamibi.(201) Tl chloride and ^99Tc^m-HL91[J].Eur J Nucl Med Mol Imaging,2002,29(8):1006-1011.
  • 4Vaupel P,Kallinowski F,Okunieff P.Blood flow,oxygen and nutrient supply and metablic microenvironment of human tumors[J].Cancer Res,1989,49(23):6449-6465.
  • 5Okada KD,Nguyen KN,Stracess HW,et al.Effects of low flow and hypoxia on myocardial retention of technetium-99m BMS181321[J].Eur J Nucl Med,1996,23(4):443-447.
  • 6Imathashi K,Morishita K,Kusuoka H,et al.Kinetics of aputative hypoxic tracer,^99Tc^m-HL91,in normoxic,hypoxic,ischemic,and stunned myocardium[J].J Nucl Med,2000,41(6):1102-1107.
  • 7Suzuki T,Nakamura K,Kawase T,et al.Monitoring of response to radiation therapy for human tumor xenografts using ^99Tc^m-HL91(4,9-diaza-3,3,10,10-tetramethyl dodecan-2,11-dione dioxime[J].Ann Nucl Med,2003,17(2):131-138.
  • 8韩春起,李亚明,任延刚,伊丽杰.^(99)Tc^m-HL91与^(99)Tc^m-MIBI在Lewis肺癌小鼠模型中的实验研究[J].中华核医学杂志,2000,20(6):269-271. 被引量:15
  • 9刘建军.^(18)F-FDG代谢显像在乳腺癌中的应用[J].国外医学(肿瘤学分册),2002,29(6):440-443. 被引量:1

二级参考文献8

  • 1Tae-Seon Kim,Woo Kyung Moon,Dong-Soo Lee,June-Key Chung,Myung Chul Lee,Yeo-Kyu Youn,Seung Keun Oh,Kuk Jin Choe,Dong-Young Noh. Fluorodeoxyglucose Positron Emission Tomography for Detection of Recurrent or Metastatic Breast Cancer[J] 2001,World Journal of Surgery(7):829~834
  • 2Holger Schirrmeister,Thorsten Kühn,Albrecht Guhlmann,Claudia Santjohanser,Thomas H?rster,Karin Nüssle,Karin Koretz,Gerhard Glatting,Andrea Rieber,Rolf Kreienberg,Andreas C Buck,Sven N Reske. Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures[J] 2001,European Journal of Nuclear Medicine and Molecular Imaging(3):351~358
  • 3Flavio Crippa,Ettore Seregni,Roberto Agresti,Carlo Chiesa,Claudio Pascali,Anna Bogni,Donatella Decise,Vinicio De Sanctis,Marco Greco,Maria Grazia Daidone,Emilio Bombardieri. Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation[J] 1998,European Journal of Nuclear Medicine(10):1429~1434
  • 4丁虹,王淑敏,朱承谟.常用肿瘤显像剂及其临床应用[J].中华核医学杂志,1999,19(1):60-62. 被引量:8
  • 5姚稚明,刘秀杰,史蓉芳,郭风,刘蕴忠,王琦,魏红星,朱霖.^(99)Tc^m-PnAO-硝基咪唑和^(99)Tc^m-HL91对乏氧心肌的实验研究[J].中华核医学杂志,1999,19(2):85-88. 被引量:18
  • 6李莉.抗癌新药dFdC及其放射增敏效应[J].国外医学(放射医学核医学分册),1999,23(3):120-123. 被引量:2
  • 7李莉.乏氧组织显像剂研究最新进展[J].国外医学(放射医学核医学分册),1999,23(3):134-139. 被引量:14
  • 8陈跃,莫廷树,匡安仁.肿瘤乏氧组织显像剂研究进展[J].国外医学(放射医学核医学分册),1999,23(6):257-260. 被引量:4

共引文献17

同被引文献18

  • 1许金全.放疗和博宁治疗骨转移癌疼痛的疗效观察[J].中国误诊学杂志,2004,4(1):44-45. 被引量:6
  • 2李家,牟巨伟,战军,曹秀华.^(99m)Tc-MIBI肺三相显像诊断肺癌的研究[J].中华核医学杂志,1994,14(2):78-80. 被引量:10
  • 3Tatsumi M,Yutoni K,Kusuoka H.et al.Teclmetium-99m-HL91 uptake as tumor hypoxia maAer:relationship to tumor blood flow[J].Eur J Nucl Med,1999,26(2):91-94.
  • 4Kinuya s,Yokoyama K,Li XF,et al.Hypoxia indueed alteration of tracer accumulation in cultured cancer cells and xenografts in mice:implications for pre抽ereapeutic prediction of treatment outcomes with 99(m)Tc-sestamibi.(201)T1 chloride and 99(m)Tc-HL91[J].Eur J Nucl Med Mol Imaging,2002,29(8):1006-1011.
  • 5Harris A L.Hypoxia-a key regulatory factor in tumor growth[J].Nat Rev Cancer,2002,2(1):38-47.
  • 6Muller B,Guth-Tongelides B,Crcutzig H,et al.Imaging of malignant tumors with ^99Tc^m -MIBI SPECT.J Nucl Med,1987;28(4):562.
  • 7Wakasugi S,Hatushiba K,Watanabe M,et al.High accumulation of ^99Tc^m-MIBI in bone.J Nucl Med,1999;40(5 SUPPL):211.
  • 8Moulopoulos LA,Dimopoulos M.Magnetic resonance imaging of the bone marrow in hematologic.Blood,1997;90(6):2127-2138.
  • 9Wakasugi S,Ohta K,Hasegawa Y,et al.Detection of minimal residual disease in acute leukemia by ^99Tc^m-MIBI femoral marrow imaging.Clinical Nuclear Medicine,2001;26(4):325-330.
  • 10Wakasugi S,Noguti A,Katuda T,et al.Potential of ^99Tc^m-MIBI for detecting bone marrow metastases.J Nucl Med,2002;43(5):596-602.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部